256,95 €
256,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
128 °P sammeln
256,95 €
256,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
128 °P sammeln
Als Download kaufen
256,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
128 °P sammeln
Jetzt verschenken
256,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
128 °P sammeln
  • Format: PDF

Outlines recombinant glycoprotein expression in different host systems
Discusses the role of glycosylation on protein function and vaccine development
Updates on cutting edge glycoanalytical technologies
Sets out future directions in glycobiotechnology and glycoanalysis

  • Geräte: PC
  • ohne Kopierschutz
  • eBook Hilfe
  • Größe: 13.63MB
Produktbeschreibung
Outlines recombinant glycoprotein expression in different host systems

Discusses the role of glycosylation on protein function and vaccine development

Updates on cutting edge glycoanalytical technologies

Sets out future directions in glycobiotechnology and glycoanalysis


Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Dr. Erdmann Rapp is heading the Bio/Process Analytics team of the Bioprocess Engineering Department at the Max Planck Institute for Dynamics of Complex Technical Systems in Magdeburg and founder, CEO & CSO of glyXera, providing tailored cutting-edge glycoanalytical products and services. He is an experienced researcher, inventor, mentor and university lecturer. He and his team are working on the development and implementation of innovative bio/process analytics - in particular, on sophisticated tools for proteomics, glycoproteomics and glycomics - for a deeper understanding of biological and biotechnological processes. Dr. Rapp's successful research is documented by more than 120 peer-reviewed papers and book chapters, and 8 patents. Professor Udo Reichl is a Scientific Member of the Max Planck Society, Director of the Bioprocess Engineering Department of the Max Planck Institute for Dynamics of Complex Technical Systems in Magdeburg and Chair of Bioprocess Engineering at the Otto-von-Guericke University Magdeburg. He has profound expertise in the development and optimization of cell culture-based viral vaccine production. His group developed sophisticated analytical tools to monitor process dynamics, metabolism of cell lines, infection dynamics and the glycosylation of viral and recombinant proteins. His list of publications comprises more than 250 peer-reviewed papers and book chapters, and he has filed various patents.